Patients, Doctors and Researchers Commend the FDA for Proposal to Modernize Oversight of Laboratory Developed Tests
The American Cancer Society Cancer Action Network (ACS CAN) together with a dozen groups representing patients, doctors and researchers submitted a letter to the Food and Drug Administration today commending the agency for a proposal that aims to implement appropriate and efficient oversight of laboratory developed tests (LDTs).